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Materials and Methods 
Cascade expression and purification 
The protein and RNA components of Cascade were cloned and co-expressed in E. 
coli Bl21 (DE3) cells using four different expression vectors (7, 8, 12). Expression was 
induced using 0.2 mM isopropyl-β-D-1-thiogalactopyranoside (IPTG) at OD600nm=0.5, 
and grown overnight at 16-18°C. Cells were pelleted by centrifugation (5,000g for 10 
min), suspended in lysis buffer (100mM Tris-HCl pH 8.0, 150mM NaCl, 1mM EDTA, 
and 1mM TCEP), and frozen at -80°C. Cells were lysed by sonication and lysates were 
clarified by centrifugation (22,000g for 20 min). The protein and RNA components of 
Cascade self-assemble in vivo and the complex was affinity purified using an N-terminal 
Strep-II tagged Cse2 subunit with Strep-Tactin Superflow Plus resin (Qiagen). Cascade 
was eluted from the Strep-Tactin resin in lysis buffer containing 2.5 mM desthiobiotin. 
The Strep-II tag was removed with HRV-3C protease, followed by a second purification 
using the Strep-Tactin Superflow Plus resin. Cascade was concentrated and further 
purified using a HiLoad 16/60 Superdex200 gel filtration column (GE Healthcare) 
equilibrated with gel filtration buffer (50mM Tris-HCl, pH 7.5). 
 
Cascade crystallization and structure determination 
Cascade crystals were grown at 4, 12, 18 and 24°C from equal volumes (2µl + 2µl) of 
concentrated Cascade protein solution (A280=30 to 45) and mother liquor (0.1 M HEPES 
pH 6.5-7.5, 0.05 – 0.20 M NaSCN, 0.150 NaCl, and 8-14% (w/v) PEG 8000) using 
hanging drop vapor diffusion or microbatch. Hanging drop experiments were carried out 
using EasyXtal 15-Well DG-Tool (Qiagen) plates and microbatch experiments were 
performed using Impact Plates (HR3-293 Hampton Research), and ClearSeal film (HR4-
521). Cascade crystals generally appeared after one to two weeks of incubation and were 
cryo-protected for x-ray diffraction experiments using a stepwise exchange within the 
crystallization drop that gradually increased the concentration of PEG 400 to 20% (v/v). 
In the initial step, 1µl of mother liquor containing a 5% higher concentration of PEG 
8000 was added to the drop. The concentration of PEG 400 was then raised from 0-20% 
in 5% v/v increments by removing 1µl of the crystallization drop and adding 1 µl of cryo-
protectant solution. After about 30 seconds in the final cryo-protectant, crystals were 
scooped and flash-cooled in liquid Nitrogen. Diffraction data were collected at beamline 
4.2.2 of the Advanced Light Source (Lawrence Berkeley National Laboratory), beamlines 
19-ID and 23-ID of the Advanced Photon Source (Argonne National Laboratory), and 
beamline 12-2 of the Stanford Synchrotron Radiation Light source (SLAC National 
Accelerator Laboratory). Data processing was carried out using HKL2000, XDS, and 
Aimless (39-41). The data collection statistics are shown in Table S1. The crystals belong 
to space group P212121 and contain two molecules of Cascade in the asymmetric unit 
related by non-crystallographic symmetry.  
The 8 Å cryo-EM structure was used as a search model for molecular replacement 
using Phaser (42). Two copies were found with a clear signal (TFZ=20.3 for the second 
copy), and scale factor refinement reduced the magnification of the cryo-EM structure by 
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a factor of 0.949. Phases were improved and extended to 3.24 Å by iterative rounds of 
density modification using the Autobuild wizard (43) of the Phenix software suite (44). 
Density modification included non-crystallographic symmetry (NCS) averaging both 
over the two copies of the Cascade complex and over the multiple copies of the Cas7 and 
Cse2 subunits within each complex. NCS operators within the copies of the complex 
were identified using phenix.find_ncs_from_density (16). The final atomic model was 
completed using iterative rounds of model building in COOT (45), refinement with 
Phenix.refine (46), and validation using Molprobity (47). Refinement statistics for the 
model are provided in Table S1. 
 
Labeling of oligonucleotides 
Oligonucleotides (Integrated DNA Technologies) listed in Table S2 were 5’-end 
labeled with γ32P-ATP (PerkinElmer) using T4 polynucleotide kinase (NEB). Labeled 
oligonucleotides were purified by phenol/chloroform extraction followed by Micro Bio-
Spin P-30 columns (Bio-Rad). dsDNA was prepared by mixing labeled oligonucleotides 
with a >10 times molar excess of the complementary oligonucleotide, in hybridization 
buffer (20mM HEPES pH 7.5, 75mM NaCl, 2mM EDTA, 10% glycerol, and 0.01% 
bromophenol blue). The mixture was incubated at 95°C for 5 minutes, and gradually 
cooled to 25°C in a thermocycler. Duplexed oligonucleotides were further purified by 
15% native polyacrylamide gel (1x TBE buffer run at 25mA for 40 minutes at 4°C), and 
recovered from the gel by overnight precipitation.  
 
Electrophoretic Mobility Shift Assay (EMSA) 
Increasing concentrations of Cascade were incubated with oligonucleotides in a 
buffer containing 20mM HEPES pH 7.5, 75 mM NaCl, 2 mM EDTA, 1 mM TCEP 10% 
glycerol and 0.01% bromophenol blue. Samples were incubated for 30 minutes at 37°C 
and loaded onto a 6% native polyacrylamide gel and visualized using a phosphorimager 
(GE Healthcare). Gels were dried, exposed to phosphor storage screens, and scanned with 
a Typhoon (GE Healthcare) phosphorimager. The signals from the bound and unbound 
DNA fractions were quantified using ImageQuant software (GE Healthcare). After 
background subtraction, the fractions of bound oligonucleotides were plotted against the 
total Cascade concentration. The data were fit by nonlinear regression analysis using the 
equation: 
 
 
 
Where M1 is the amplitude of the binding curve. Reported KDs are the average of three 
independent experiments. 
 
Structure alignments and graphical rendering 
Comparison of homologous structures was performed using the secondary structure 
matching tool in COOT (45), or with the align tool in PyMol (48). Figures were rendered 
using PyMol or Chimera (48, 49). Movies were made using Chimera (49).
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Fig. S1. 
Electron Density of Cascade. Electron density map (mesh) at 3.24 Å resolution obtained 
by molecular replacement using the EM density, followed by averaging over non-
crystallographic symmetry. The refined model of Cascade is shown as sticks. 
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Fig. S2. 
Superposition of the two Cascade molecules in the asymmetric unit. (A) The 
asymmetric unit contains two molecules of Cascade. (B) The two molecules superimpose 
with an rmsd of 1.29 Å. The primary difference between the two molecules is a rotation 
of the head. 
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Fig. S3. 
Schematic of amino acid contacts with the crRNA. Amino acids are shown using three 
letter abbreviations and colored according to the key in the lower right corner. The 
segments of the crRNA are labeled and kinked bases are numbered. 
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Fig. S4. 
Structural Comparison of Cas6e proteins. (A) Structure of E. coli Cas6e (yellow) 
bound to the 3’-end of the crRNA. (B) Structure of T. thermophilus Cas6e (gray) bound 
to a non-hydrolysable substrate (PDB: 2Y8W) (18). This structure reveals protein 
specific interaction 3’ of the cleavage site. (C) Superposition of E. coli Cas6e (yellow) 
and T. thermophilus Cas6e (gray). The extended RNA “groove-binding loop” in the E. 
coli protein is labeled. (D) Cartoons of the E. coli Cas6e (yellow), T. thermophilus Cas6e 
(gray) and their respective crRNA sequences. Together these structures suggest that 
Cas6e proteins recognize bases on both sides of the stem-loop and that after cleavage 
Cas6e releases the 3’ cleavage product (far right).
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Fig. S5. 
Structural similarities between Cas7 CRISPR proteins.  (A) The three different 
morphologies of the Cas7 proteins from Cascade are shown in complex with their 
respective crRNA substrates. (B) Structural alignments of the different morphologies of 
Cas7. The thumb of Cas7.1 is rotated 73˚ relative to Cas7.5 (left). The thumb of Cas7.1 
also forms a short helix that fits into the hydrophobic groove of Cas6e, serving as a tether 
between the head and backbone. The finger domain of Cas7.6 is rotated 180˚ relative to 
Cas7.5 (right). (C) Cas7 homologues in different CRISPR systems and their structural 
similarities to Cas7.5. Both Csa2 (Type I-A) (23) and Csm3 (Type III-A) (22) exhibit 
similar architecture to the Cas7 protein from E. coli, consisting of a modified RRM (palm 
domain), a helical fingers domain and two loops that make the webbing between the palm 
and thumb. The thumb is disordered in Csa2 and Csm3, however the structural 
similarities suggest a conserved role for the thumb in assembly of the Cas7 backbone 
across diverse CRISPR systems. 
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Fig. S6.  
Surface features of Cascade. (A) Cascade shown as surface representation and colored 
by conservation. Conserved residues are colored orange and variable residues are white. 
(B) Individual components of Cascade colored by conservation. The palm and thumb of 
Cas7 proteins are the most conserved surfaces. (C) Cascade shown as an electrostatic 
surface. Positively charged residues are colored blue, negative as red and hydrophobic as 
white. (D) Individual components of Cascade colored according to electrostatic surface 
potential. The nucleic acid binding surfaces are positively charged. 
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Fig. S7.  
Every 6th-nucleotide of the crRNA-guide does not participate in target recognition. 
(A) Data from electrophoretic mobility shift assays of dsDNA substrates that contain 
mismatches with the crRNA at 6-nt intervals (Fig. 4D). The data were fit with a standard 
binding isotherm (Materials and Methods). The concentrations of Cascade are 0, 0.1 pM, 
0.5 pM, 1 nM, 5 nM, 10 nM, 100 nM, 1 uM, and 10 uM. (B) Average KD and standard 
error of the mean (SEM) from three independent experiments are plotted for each of the 
four different dsDNA substrates (Table S2). 
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Fig. S8.  
Cse2 proteins form a dimer that assembles along the belly of Cascade. (A) Two Cse2 
proteins form a dimer that parallels the helical Cas7 backbone and connects the head 
(Cas6e) to the tail (Cse1) of Cascade. Each Cse2 protein contacts three Cas7 subunits 
through interactions with the thumb and webbing motifs. (B) Two parallel tracks of 
positive surface charge (dashed yellow line) may stabilize the target and displaced strand 
of DNA. 
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Fig. S9.  
Structures of Cas5 proteins. (A) Atomic models of six Cas5-like proteins from Type I 
and Type III immune systems. Each of the structures consists of a modified RRM and a 
thumb. The structures were superimposed using the secondary structure matching 
program in COOT (45). The only structure that contains RNA is Cas5e from Cascade, 
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however the crRNA binding pocket appears to be conserved in the other Cas5-like 
structures and the 5’-handle of the crRNA has been modeled into the binding pocket of 
these structures. (B) Surface representation of the Cas5-like proteins with the 5’-handle 
of the crRNA modeled according to panel A. (C) Electrostatic surface representation of 
the Cas5-like proteins with the 5’-handle of the crRNA modeled according to panel A. 
(D) Superposition of the E. coli Cas5e and B. halodurans Cas5c (29). (E) A co-crystal 
structure of Cmr3 (red) and Cmr2 (pink) from P. furiosus (50). Cmr3 (red) is a Cas5-like 
protein that may cap the end of the CMR complex. The N-terminal RRM of Cmr3 and 
Cas5d are superimposed. Superposition of the Cmr3-Cmr2 complex onto Cas5e positions 
the Cmr2 protein in a similar location to Cse1 in Cascade (far right). 
 
 
14 
 
 
Fig. S10.  
Docking the atomic model of Cascade into the cryo-EM density of Cascade bound to 
dsDNA. (A) Atomic models of Cascade docked into the cryo-EM density of Cascade 
bound to dsDNA. The dsDNA target is shown as a red surface. There is a 16 Å gap 
between the finger domains of the Cas7 proteins except between Cas7.5 to Cas7.6. A 
conformational change in Cas7.6 creates a larger gap between Cas7.5 and Cas7.6 
subunits allowing space for a nucleic acid duplex. (B) Zoomed in view of dsDNA target 
bound to Cascade. Lysine-rich helices on the finger domains of Cas7.5 and Cas7.6 are 
positioned to interact with the negatively charged backbone of the dsDNA target. 
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Fig. S11.  
Conserved mechanism for recognition of the 5'-handle. (A) Superposition of Cas5e 
from E. coli Cascade and Cas5d from Bacillus halodurans (PDB: 4F3M) (29). Cas5d has 
an additional C-terminal extension that contains an endonuclease active site (red). (B) 
The aligned 5'-handle from E. coli is modeled onto the surface of Cas5d and the putative 
trajectory of the extra three nucleotides observed in Type IC repeats is indicated with a 
dashed line. (C) Schematic of Cas6e-mediated crRNA processing and Cas5e binding in 
CRISPR subtype IE. (D) Schematic of a putative Cas5d-mediated crRNA processing 
mechanism in CRISPR subtype IC, in which Cas5d recognizes the 5'-handle sequence. 
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Fig. S12. 
Cse1 is a metal binding protein. (A) Cse1 (purple) is a large two-domain protein 
consisting of a unique globular fold and a C-terminal four-helix bundle. The globular 
domain contains a metal-ion coordinated by four cysteines (black box). The inset on the 
right shows the electron density map (white mesh), model of the Cse1 metal binding site 
(purple) and the metal-ion (blue). (B) Excitation scan indicating that zinc is present in the 
crystal. (C) Fluorescence scan indicating that zinc is present in the crystal. 
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Fig. S13. 
A-form ordering of RNA by diverse protein platforms. (A) The crystal structures of E. 
coli Cascade, Cas9 (PDB: 4OO8), and Argonaute (PDB: 4OLA) with guide RNAs 
(above). The protein in each of these systems pre-orders the RNA in a pseudo A-form 
conformation (below).
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Table S1. Data collection and refinement statistics 
 
Crystal morphology Shard 
Data collection  
Beamline 
Space group 
SSRL 12-2 
P212121 
Cell dimensions    
    a, b, c (Å) 201.0, 214.4, 217.9 
    a, b, g  (°)  90.0, 90.0, 90.0 
CC1/2 0.994 (0.736) 
Completeness (%) 99.9 (100.0) 
Redundancy 6.8 (6.9) 
Rmerge(%) 14.1 (92.6) 
I / σI  8.5 (2.2) 
  
Refinement 
Resolution† (Å) 39-3.24 (3.35-3.24)* 
No. reflections 174565 
Rwork/Rfree (%) 22.09/26.47 
No. non-hydrogen atoms 53326 
    Marcomolecules 
    Zn  
53324 
2 
Mean B-factors 89.5 
    Macromolecules 89.5 
    Zn 182.8 
RMSD  
   Bond lengths (Å) 0.008 
   Bond angles (deg) 
Ramachandran 
    Favored (%) 
    Outliers (%) 
Clashscore 
1.42  
 
96 
0.17 
14.2 
  
*Values in parentheses are for highest-resolution shell. 
†Resolution limits use the criterion of I/σI > 2.0 
CC1/2 is the percentage of correlation between intensities from random half-datasets (51). 
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Table S2. DNA substrates used for band shift assays. 
Description Sequence 
Target strand (top) and non-target strand (bottom);  
PAM in black; the target is blue and mutations are red 
72 bp dsDNA 100% 
complementary to 
crRNA-guide 
                        1    6     12    18    24    30 
3’-CGCGCCGTTCGGCTTTCGTACTGCCATAACAAGTCTAGGACCGAACGGTTGTCACTAACGAGCCCTCAGCGA-5’ 
5’-GCGCGGCAAGCCGAAAGCATGACGGTATTGTTCAGATCCTGGCTTGCCAACAGTGATTGCTCGGGAGTCGCT-3’ 
 
72 bp dsDNA with 
mutations at 
positions 5, 11, 
17, 23, and 29. 
                        1   5     11    17    23    29 
3’-CGCGCCGTTCGGCTTTCGTACTGCCTTAACATGTCTATGACCGTACGGTCGTCACTAACGAGCCCTCAGCGA-5’ 
5’-GCGCGGCAAGCCGAAAGCATGACGGAATTGTACAGATACTGGCATGCCAGCAGTGATTGCTCGGGAGTCGCT-3’ 
 
72 bp dsDNA with 
mutations at 
positions 6, 12, 
18, 24, and 30. 
                        1    6     12    18    24    30 
3’-CGCGCCGTTCGGCTTTCGTACTGCCACAACAATTCTAGTACCGATCGGTTTTCACTAACGAGCCCTCAGCGA-5’ 
5’-GCGCGGCAAGCCGAAAGCATGACGGTGTTGTTAAGATCATGGCTAGCCAAAAGTGATTGCTCGGGAGTCGCT-3’ 
 
72 bp dsDNA with 
mutations at 
positions 7, 13, 
19, 25, and 31. 
                        1     7     13    19    25    31 
3’-CGCGCCGTTCGGCTTTCGTACTGCCATTACAAGCCTAGGTCCGAATGGTTGCCACTAACGAGCCCTCAGCGA-5’ 
5’-GCGCGGCAAGCCGAAAGCATGACGGTAATGTTCGGATCCAGGCTTACCAACGGTGATTGCTCGGGAGTCGCT-3’ 
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Movie S1 
Cas proteins and their interactions with the crRNA. Cascade is a sea-horse-shaped 
complex designed to bind double-stranded DNA targets complementary to the crRNA-
guide sequence. The complex consists of 11 proteins and a 61-nt crRNA. The CRISPR 
locus is transcribed and partial dyad symmetry in the E. coli repeat sequence results in 
long CRISPR RNA consisting of a series of 29-nt repeats with stable stem-loop structures 
that are separated by 32-nt spacer sequences. Cas6e is a CRISPR-specific 
endoribonuclease that interacts with the crRNA stem-loop. Cas6e cleaves the crRNA on 
the 3’-side of the stem-loop forming a mature 61-nt crRNA consisting of the 32-nt spacer 
(red) flanked by portions of the repeat. After cleavage Cas6e remains tightly associated 
with the 3’ stem-loop of the mature crRNA and a hydrophobic V-shaped cleft on the back 
of Cas6e provides a binding site for a short helix from Cas7.1 that tethers Cas6e to the 
helical backbone of Cascade.  
The backbone of Cascade is composed of six Cas7 proteins that oligomerize along the 
crRNA forming an interwoven architecture that divides the crRNA in six discrete 
segments. Each Cas7 protein resembles a ‘right hand’ that grips the crRNA through non-
sequence specific interactions on the palm, web and fingers. The thumb of each Cas7 
subunit folds over the top of the RNA and slots into a positively charged crease in the 
palm of the adjacent molecule. The 8-nts on the 5’-end of the crRNA function as a 
molecular signal that initiates assembly of the tail. The Cas5e protein specifically binds 
nucleotides in the 5’-handle and a thumb folds over the top of the crRNA and arches 
across the palm of Cas7.6. The Cas5e thumb creates a pore that provides access to 
nucleotides in the 5’-handle. This pore is a docking module for a short helix on Cse1. The 
two Cse2 subunits assemble along the belly of Cascade. Although the Cse2 subunits do 
not make direct contacts with the crRNA, electrostatic calculations show that both faces 
of the Cse2 dimer are positively charged, indicating a possible role for Cse2 in stabilizing 
the bound and displaced strands of the DNA target. 
The interlocking assembly of the Cascade backbone segments the crRNA into six 
sections. The first five segments consist of a buried nucleotide followed by five solvent 
accessible bases that are ordered in a pseudo A-form configuration. Previous biochemical 
and genetic studies has shown that the nucleotides in segment 1 (positions 1-5) are 
critical for target recognition. This portion of the crRNA-guide is called the ‘seed’ 
sequence and it has been suggested that helical ordering of these bases may explain their 
importance in target binding. However, the helical arrangement of bases in segment 1 are 
not significantly different from those in segments 2, 3, 4, and 5, suggesting that the 
importance of the seed may have more to do with its proximity to the PAM, rather than 
preferential pre-ordering of the bases.  
A surface representation of Cascade colored according to phylogenetic conservation. 
White signifies variable, while residues colored orange are conserved. Disassembly of the 
complex into individual subunits reveals that the most highly conserved subunits appear 
along the palm, web and finger domains of Cas7. 
 
